From drought to demand: Biotech IPOs roar back with Kailera and Alamar [Yahoo! Finance Canada]
Alamar Biosciences, Inc. - Class A common stock (ALMR)
Company Research
Source: Yahoo! Finance Canada
The Alamar Biosciences CEO's IPO was one of two back-to-back blockbuster biotech offerings this week, a clear signal that investors are willing to for life sciences companies again—under the right conditions. On Thursday, Kailera Therapeutics, an obesity drug developer, raised in what is believed to be the in Nasdaq history. The IPO priced 39.1 million shares at $16 (the top of its range). The company had initially set out to raise just $500 million. One day post-IPO, Kailera was 63 percent. On Friday, Alamar Biosciences, a precision proteomics (the study of proteins rather than genes) firm, priced its own upsized offering at $17 per share (the top of its range) raising $191.3 million after demand exceeded available shares by 11 times, Luo told Fortune . Much like Kailera, Alamar shares , up 33% on the first day of trading. For Alamar in particular, the listing carries symbolic weight. The life sciences tools and diagnostics sector has been effectively shut out of the public mar
Show less
Read more
Impact Snapshot
Event Time:
ALMR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALMR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALMR alerts
High impacting Alamar Biosciences, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
ALMR
News
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Alamar Biosciences: Looking For An Early Detection [Seeking Alpha]Seeking Alpha
- From drought to demand: Biotech IPOs roar back with Kailera and Alamar [Yahoo! Finance]Yahoo! Finance
ALMR
Sec Filings
- 4/21/26 - Form EFFECT
- 4/20/26 - Form 4
- 4/20/26 - Form 4
- ALMR's page on the SEC website